Related Experiment Videos
Bone formation induced in an infant by systemic prostaglandin-E2 administration
H R Jørgensen1, H Svanholm, A Høst
1Department of Orthopedics, Odense University Hospital, Denmark.
Insights
Long-term prostaglandin E2 (PGE2) treatment in newborns with congenital heart disease can cause bone hyperostosis. This condition, characterized by rapid bone formation, may show signs of reversibility after treatment cessation.
Area of Science:
- Pediatric Cardiology
- Developmental Biology
- Skeletal Biology
Background:
- Ductus-dependent congenital heart disease requires interventions like prostaglandin E2 (PGE2) to maintain systemic circulation.
- Systemic administration of PGE2 is a critical treatment for specific congenital heart conditions in neonates.
Observation:
- A case study involving a newborn treated with long-term systemic prostaglandin E2 (PGE2) for congenital heart disease is presented.
- Radiographic imaging after 46 days of PGE2 treatment revealed cortical hyperostosis in the long bones.
Findings:
- Histological examination of tubular bones confirmed hyperostosis, likely resulting from rapid primitive bone formation induced by PGE2.
- Bone resorption on the outer cortical surface and new bone formation on the inner surface were observed, suggesting a potential reversible phase post-treatment.
Implications:
- This case highlights a potential adverse skeletal effect of prolonged PGE2 administration in neonates.
- Understanding the bone remodeling dynamics associated with PGE2 is crucial for managing treatment protocols and monitoring infants.
- Further research into the reversibility and long-term skeletal consequences of PGE2 therapy is warranted.
Abstract:
We report a case of long-term systemic administration of prostaglandin E2 (PGE2) to a newborn infant with ductus-dependent congenital heart disease. After 46 days of treatment, radiography showed cortical hyperostosis of the long bones. The child died 62 days after discontinuation of prostaglandin treatment. Histologic examination of tubular bones showed hyperostosis presumably due to prostaglandin-induced rapid formation of primitive bone. The additional finding of extensive resorption of the outer cortical surface and bone formation at the inner surface suggested a reversible phase after discontinuation of treatment.